K Pharma,Inc.
4896.TJPXHealthcareBiotechnology
Latest quote
¥772
+¥11.00 · +1.45%
4896.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteK Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Komei Fukushima
- Listed since
- Oct 17, 2023
- Employees
- 20
Market position
Day range
Current ¥772
52-week range
Current ¥772
- Open
- ¥761
- Previous close
- ¥761
- Volume
- 6.5K
- 0.28× average
- Average volume
- 23.11K
- Average daily volume
- Market cap
- 8.97B JPY
- Beta
- 0.43
- Market reference 1
- 50-day average
- ¥711.54
- +8.50% above average
- 200-day average
- ¥715.89
- +7.84% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -8.61×
- P/B (TTM)
- 11.6×
- P/S (TTM)
- 0×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
Financial health
- Debt / equity
- 2.12×
Financial statements
Income trends
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 1B JPY | — | — |
| Cost of goods sold | — | — | 90M JPY | — | 6.8M JPY |
| Gross profit | — | — | 910M JPY | — | −6.8M JPY |
| Research and development | — | 451.64M JPY | — | 163.97M JPY | 134.52M JPY |
| Selling, general, and administrative | 916.06M JPY | 379.37M JPY | −1K JPY | 169.38M JPY | 67.97M JPY |
| Operating expenses | 916.06M JPY | 836.35M JPY | 543.94M JPY | 353.77M JPY | 212.69M JPY |
| Interest income | 3M JPY | 265K JPY | 16K JPY | 7K JPY | 1K JPY |
| Interest expense | 7.31M JPY | — | 11.85M JPY | — | — |
| Depreciation and amortization | — | — | 1K JPY | — | 6.8M JPY |
| Operating income | −916.06M JPY | −836.35M JPY | 366.06M JPY | −353.77M JPY | −219.49M JPY |
| Net income | −993.23M JPY | −846.46M JPY | 260.33M JPY | −392.43M JPY | −228.72M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- -20.83
EPS: actual versus estimate
Recent quarterly results
4896.T peers
Continue in GoAI
Research 4896.Tresearch.disclaimer